Literature DB >> 9488473

Hepatitis B virus pX targets TFIIB in transcription coactivation.

I Haviv1, M Shamay, G Doitsh, Y Shaul.   

Abstract

pX, the hepatitis B virus (HBV)-encoded regulator, coactivates transcription through an unknown mechanism. pX interacts with several components of the transcription machinery, including certain activators, TFIIB, TFIIH, and the RNA polymerase II (POLII) enzyme. We show that pX localizes in the nucleus and coimmunoprecipitates with TFIIB from nuclear extracts. We used TFIIB mutants inactive in binding either POLII or TATA binding protein to study the role of TFIIB-pX interaction in transcription coactivation. pX was able to bind the former type of TFIIB mutant and not the latter. Neither of these sets of TFIIB mutants supports transcription. Remarkably, the latter TFIIB mutants fully block pX activity, suggesting the role of TFIIB in pX-mediated coactivation. By contrast, in the presence of pX, TFIIB mutants with disrupted POLII binding acquire the wild-type phenotype, both in vivo and in vitro. These results suggest that pX may establish the otherwise inefficient TFIIB mutant-POLII interaction, by acting as a molecular bridge. Collectively, our results demonstrate that TFIIB is the in vivo target of pX.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488473      PMCID: PMC108871          DOI: 10.1128/MCB.18.3.1562

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  The human CCG1 gene, essential for progression of the G1 phase, encodes a 210-kilodalton nuclear DNA-binding protein.

Authors:  T Sekiguchi; Y Nohiro; Y Nakamura; N Hisamoto; T Nishimoto
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

2.  Interaction between a transcriptional activator and transcription factor IIB in vivo.

Authors:  J Colgan; S Wampler; J L Manley
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

3.  Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation.

Authors:  S G Roberts; I Ha; E Maldonado; D Reinberg; M R Green
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

4.  A direct interaction between a glutamine-rich activator and the N terminus of TFIIB can mediate transcriptional activation in vivo.

Authors:  J Colgan; H Ashali; J L Manley
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

5.  The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax.

Authors:  O Faktor; Y Shaul
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

6.  Identification of three essential regions of hepatitis B virus X protein for trans-activation function.

Authors:  M Arii; S Takada; K Koike
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

7.  Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.

Authors:  A S Kekulé; U Lauer; L Weiss; B Luber; P H Hofschneider
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

8.  The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.

Authors:  H S Chen; S Kaneko; R Girones; R W Anderson; W E Hornbuckle; B C Tennant; P J Cote; J L Gerin; R H Purcell; R H Miller
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.

Authors:  M A Feitelson; M Zhu; L X Duan; W T London
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II.

Authors:  I Ha; S Roberts; E Maldonado; X Sun; L U Kim; M Green; D Reinberg
Journal:  Genes Dev       Date:  1993-06       Impact factor: 11.361

View more
  42 in total

1.  Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression.

Authors:  S Barnabas; O M Andrisani
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.

Authors:  H K Jang; R A Albrecht; K A Buczynski; S K Kim; W A Derbigny; D J O'Callaghan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

Review 4.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx.

Authors:  Tianyu Jiang; Minhao Liu; Jianping Wu; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 6.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 7.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

8.  Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha.

Authors:  R Weil; H Sirma; C Giannini; D Kremsdorf; C Bessia; C Dargemont; C Bréchot; A Israël
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

9.  Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.

Authors:  G Waris; K W Huh; A Siddiqui
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 10.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.